What is in the CJC-1295 & Ipamorelin blend?
CJC-1295 and ipamorelin are one of the most commonly paired research peptide combinations. This vial contains both, with 10mg of peptide in total.
- CJC-1295: a modified GHRH(1-29) analogue that acts on the GHRH receptor. It exists in two forms, with DAC and without DAC; check the label for the form in your batch.
- Ipamorelin: a synthetic pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2) that acts selectively on the ghrelin (GHS) receptor.
CJC-1295 & Ipamorelin vs Mod GRF 1-29 & Ipamorelin
We list two similar blends. The Mod GRF 1-29 & Ipamorelin Blend always contains CJC-1295 without DAC. The name “CJC-1295” is used for two different compounds:
- CJC-1295 with DAC: the 29-amino-acid GHRH analogue plus a drug affinity complex (a lysine-linked maleimide group) that lets it bind albumin in the blood. In published human studies this extended its half-life to several days.
- CJC-1295 without DAC (Mod GRF 1-29): the same 29 amino acids with no albumin-binding linker, so it is cleared within minutes to hours.
The ipamorelin part and the 10mg total are the same in both blends. Ask us which CJC-1295 form your batch contains before ordering; it is also stated on the certificate of analysis.
Regulatory status
Neither peptide is an approved medicine. GHRH analogues and growth hormone secretagogues are prohibited at all times in competitive sport by the World Anti-Doping Agency. This product is sold for laboratory research use only.
Related products
- Each peptide on its own: CJC-1295 with DAC, CJC-1295 without DAC and Ipamorelin.
- Other ipamorelin combinations: Mod GRF 1-29 & Ipamorelin, Sermorelin & Ipamorelin and Fragment 176-191, CJC-1295 & Ipamorelin.
Handling and research-use notice
Store and handle this material as stated on the label and certificate of analysis for your batch; see our guide to storing research peptides. This product is sold for laboratory research use only. It is not a medicine or supplement and is not for human or veterinary use.




Reviews
There are no reviews yet.